MedAware, a Ra’Anana, Israel-based developer of big data analytics for the medical prescription market, completed a $1m Series A financing.
The round was led by equity crowdfunding platform OurCrowd and GE Ventures.
The company intends to use the funds to drive initial sales to healthcare providers, insurance companies and large pharmacy chains.
Founded in 2012 by CEO Gidi Stein, MedAware provides patent-pending technology that uses big data analytics and machine learning algorithms to analyze large scale data of Electronic Medical Records (EMRs), to learn automatically how physicians treat patients in real life scenarios. The company is led by an expert team with extensive clinical, business and technical experience.
FinSMEs
02/10/2014